Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a natural antisense transcript (NAT) to the MIER2 gene. NATs are endogenous RNA molecules transcribed from the opposite strand of protein-coding genes, and can regulate gene expression of their sense counterpart at multiple levels, including transcription, splicing, RNA stability, transport, and translation[3][4]. The specific transcript "novel transcript, antisense to MIER2" appears to be cataloged based on its sequence but lacks detailed functional characterization and direct links to disease, drug interactions, or classical therapeutic targeting[1]. NATs in general are implicated in fine-tuning gene expression and may participate in cellular regulatory networks, but individual NATs are rarely considered primary therapeutic targets unless well-validated[3][4].
Not applicable, as it is not a druggable protein or receptor. Mechanistically, natural antisense transcripts can regulate gene expression mainly by: - RNA masking: Sense-antisense RNA duplex formation blocking protein or miRNA interactions - Transcriptional interference: Disruption of transcription of the sense gene - Epigenetic regulation: Recruiting chromatin modifiers to change gene accessibility
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to MIER2 (ENSG00000267124).